PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
03-Jun-2024 MedTech Outlook 2024 for Latin America Released AccessWire
03-Jun-2024 PharmaNest to Present Seven Digital Pathology and AI Communications and Abstracts at the International Liver Congress — EASL 2024, Including Analytical and Clinical Validation AccessWire
03-Jun-2024 Enzolytics, Inc. Poised to Invest Alongside Sagaliam Acquisition Corp in Revolutionary Room Temperature SPAD Technology AccessWire
03-Jun-2024 TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) AccessWire
03-Jun-2024 Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024 AccessWire
03-Jun-2024 CNS Pharmaceuticals Announces Reverse Stock Split AccessWire
03-Jun-2024 Aptevo Participating in the BIO International Convention AccessWire
03-Jun-2024 Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024 Mainz BioMed N.V.
03-Jun-2024 Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survival Versus KEYTRUDA in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection AccessWire
03-Jun-2024 Modular Medical Announces Addition to the Russell Microcap(R) Index AccessWire
03-Jun-2024 Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year AccessWire
03-Jun-2024 Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference AccessWire
03-Jun-2024 SK pharmteco et ART-TG accueillent le premier symposium international Momentum in Cell & Gene Therapy en France Andrew Lloyd Associates
31-May-2024 Spexis receives second extension for the publication of its 2023 annual report until July 31, 2024, releasing its unaudited financial statements and providing an update on its dispute with SPRIM. Spexis AG
31-May-2024 Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference AccessWire
31-May-2024 KindlyMD Announces Pricing of $6.8 Million Initial Public Offering AccessWire
31-May-2024 Anocca Appoints Christiane Hanke-Harloff to Board of Directors Anocca
31-May-2024 Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R) AccessWire
31-May-2024 Cloud DX Reports Results for the First Quarter of 2024 AccessWire
31-May-2024 InnoSIGN Launches New Suite Products for Pharmaceutical Research and Clinical Studies AccessWire